Speaker Details

Jenny Eileen Murase, MD, FAAD

Jenny Eileen Murase, MD, FAAD

SESSIONS

F003 Psychocutaneous Disease: Treating the Difficult Patient
Mar 8, 2024 • 9:00 AM - 12:00 AM • Room 32B
F059 Women’s Health Therapeutic Hotline
Mar 9, 2024 • 1:00 PM - 12:00 AM • Room 28D
F064 The Pregnant Pause: How to Evaluate and Treat Your Pregnant Patients
Mar 9, 2024 • 3:30 PM - 12:00 AM • Room 28D

HANDOUTS

Login to view handouts

DISCLOSURES

AbbVie – Consultant(Honoraria), Speaker/Faculty Education(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Attovia Therapeutics – Consultant (1099 relationship)(Honoraria); Blueprint Medicines – Advisory Board(Honoraria); Blueprints Medicine – Speaker(Honoraria); Eli Lilly – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker/Faculty Education(Honoraria); Galderma – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Incyte – Advisory Board(Honoraria); Leo Pharma – Advisory Board(Honoraria); Leo Pharma Inc – Speaker/Faculty Education(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Speaker(Honoraria); Phothera – Advisory Board(Honoraria); Regeneron – Speaker/Faculty Education(Honoraria); Sanofi – Speaker(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); UCB – Advisory Board(Honoraria), Consultant(Honoraria), Speaker/Faculty Education(Honoraria); UpToDate – Consultant(Honoraria);